Generics - GlaxoSmithKline


Current filters:


Popular Filters

1570 to 1594 of 1643 results

GSK’s Relovair likely to emerge as market leader among once-daily LABA/ICS combinations


In the asthma treatment market, at the expense of market-leading drugs that are dosed twice daily, emerging…

GlaxoSmithKlineMarkets & MarketingPharmaceuticalRelovairRespiratory and PulmonaryTheravance

AstraZeneca plans R&D center in Russia and Novartis breaks ground on new facility


In yet more illustrations of multinational drug majors getting a foot hold in the fast-growing BRIC (Brazil,…


Health care investments in GCC nations spur pharma growth, says IHS


Demand for health care services in Gulf Cooperation Council (GCC) member states is on a strong upward…


Exports will be the key driver of growth for Czech pharma, says BMI


Disputes between pharmaceutical industry associations and the Czech government have created uncertainty…

EuropeGenericsMarkets & MarketingPharmaceuticalPolitics

Adolor to pay GSK $25 million plus royalties to reacquire Entereg rights


USA-based Adolor Corp (NasdaqGM: ADLR) has reached agreement with UK pharma giant GlaxoSmithKline (LSE:…


China drug formulation market could reach $150 billion by 2015


It has been well recognized that the drug formulation has been one of the valued-added technologies for…

Asia-PacificGenericsMarkets & MarketingRegulation

US generics group GPhA voices worries on TPP agreement negotiations


The USA’s Generic Pharmaceutical Association (GPhA) says that it has sent a letter to President…

BiotechnologyGenericsMarkets & MarketingNorth AmericaPatents

GlaxoSmithKline takes full control of Neptunus JV; links with Arecor on vaccines


In one of two pieces of vaccine-related news yesterday, GlaxoSmithKline (LSE: GSK) said it is acquiring…

ArecorGlaxoSmithKlineLicensingMergers & AcquisitionsPharmaceuticalShenzhen NeptunusVaccines

Dr Reddy’s warned by US FDA over API facility in Mexico


Indian generic drug major Dr Reddy’s Laboratories (NYSE:RDY) revealed yesterday that its wholly-owned…

Dr Reddy's LaboratoriesGenericsNorth AmericaRegulationSouth America

US FDA warns on risk of more serious forms of prostate cancer with 5-ARI drugs


The US Food and Drug Administration has warned that the labeling for drugs used to treat enlarged prostate…

AvodartGlaxoSmithKlineMerck & CoNorth AmericaOncologyPharmaceuticalProscarRegulation

GlaxoSmithKline and Valeant get FDA approval for epilepsy drug Potiga


Following backing from a US Food and Drug Administration advisory panel last summer (The Pharma Letter…

GlaxoSmithKlineNeurologicalNorth AmericaPharmaceuticalPotigaRegulationTrobaltValeant Pharmaceuticals

PATH MVI partners with GSK and Crucell to develop second-generation vaccine against malaria


The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with…

CrucellGlaxoSmithKlineJohnson & JohnsonPharmaceuticalResearchTropical diseasesVaccines

Changing of the Guard begins in biotech sector


The biotechnology sector is bracing for change this year as a flurry of "biosimilar" or "biogeneric"…

BiotechnologyGenericsMarkets & MarketingNorth AmericaRegulation

Pharma majors slash vaccine prices to poorest countries


Several pharmaceutical majors, including the UK’s GlaxoSmithKline (LSE: GSK), US giants Merck &…

GardasilGlaxoSmithKlineGlobalJohnson & JohnsonMerck & CoPharmaceuticalPricingRotarixSanofiSanofi PasteurVaccines

EPHA calls for transparency of European medicines pricing


In the framework of the European Commission consultation of the possible revision of the directive on…


UK OFT evaluation of Napp case finds increased competition in morphine market


The UK’s Office of Fair Trading (OFT) has published an evaluation of its 2001 abuse of dominance…

EuropeGenericsMarkets & MarketingMorphineNapp PharmaceuticalsNeurologicalPricing

Positive Ph III results for GSK and Theravance Relovair in COPD


UK pharma giant GlaxoSmithKline (LSE: GSK) and development partner Theravance (Nasdaq: THRX) of the USA…

GlaxoSmithKlinePharmaceuticalRelovairResearchRespiratory and PulmonaryTheravance

FDA denies Citizen Petition on generic Combivir 180-day exclusivity “First Applicant” issue


Last week, in a seven-page response, the US Food and Drug Administration denied an October 18, 2010 Citizen…

CombivirGenericsLegalLupinNorth AmericaPatentsTeva Pharmaceutical Industries

Mylan to rebrand Matrix Labs and launch Rx products in India


US generics major Mylan (Nasdaq: MYL) says that it plans to rebrand its Hyderabad, India-based subsidiary…

Asia-PacificGenericsMarkets & MarketingMatrixMylan Laboratories

1570 to 1594 of 1643 results

Back to top